This inventor holds 1 USPTO granted patent. Top assignee: Hemarus Therapeutics Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Thirupati Reddy Katkuri: Innovator in Immunoglobulin Production
Introduction
Thirupati Reddy Katkuri is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of biopharmaceuticals, particularly in the production of immunoglobulins.
Latest Patents
Thirupati holds a patent for the "Process for increased yield of immunoglobulin from human plasma." This invention describes a method for large-scale production of human immunoglobulins (IgG) with high yields by utilizing an improved all-chromatography process scheme. This innovative process eliminates the need for ethanol precipitation, thereby enhancing the extraction of immunoglobulins while preserving other therapeutic proteins present in plasma. The yields achieved by this method range from 7 to 8 grams of IgG per liter of plasma. Moreover, the high-yielding process incorporates chromatographic steps paired with viral inactivation or removal procedures, ensuring that the purified immunoglobulin protein complies with pharmacopoeial limits and is suitable for therapeutic administration, specifically for normal intravenous immunoglobulin (IVIG).
Career Highlights
Thirupati Reddy Katkuri is associated with Hemarus Therapeutics Limited, a company focused on developing advanced therapeutic solutions. His work has paved the way for improved methods in the biopharmaceutical industry, showcasing his commitment to innovation and excellence in medical research.
Collaborations
Throughout his career, Thirupati has collaborated with notable researchers such as Ashok Kumar Nuvula and Zinia Chakraborty. These collaborations have further contributed to the development and refinement of his patented processes and have played a crucial role in advancing therapeutic techniques within his field.
Conclusion
Thirupati Reddy Katkuri exemplifies the spirit of innovation in biopharmaceuticals. With his groundbreaking patent, he not only enhances the yield of essential therapeutic proteins but also contributes significantly to the medical field, ultimately benefiting patients worldwide. His ongoing work at Hemarus Therapeutics Limited is expected to lead to further advancements in immunoglobulin production and other biomedical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile